Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | NP-G2-044 |
| Trade Name | |
| Synonyms | NP G2 044 |
| Drug Descriptions |
NP-G2-044 is a small molecule that inhibits fascin, resulting in aberrant actin cytoskeleton reorganization, and potentially resulting in decreased tumor cell migration and metastasis (PMID: 27071719). |
| DrugClasses | |
| CAS Registry Number | 1807454-59-6 |
| NCIT ID | C142086 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| NP-G2-044 | NP-G2-044 | 0 | 3 |
| NP-G2-044 + Pegylated liposomal doxorubicin | NP-G2-044 Pegylated liposomal doxorubicin | 0 | 1 |
| NP-G2-044 + unspecified PD-L1 antibody | NP-G2-044 unspecified PD-L1 antibody | 0 | 1 |